GeneDx Holdings Corp
WGS90.900USD
+11.190+14.04%
Cierre 06/24, 16:00（ET）Cotizaciones retrasadas 15 min
2.59BCap. mercado
PérdidaP/E TTM
Más Datos de GeneDx Holdings Corp Compañía
GeneDx Holdings Corp. is a genomics company. The Company operates, through its subsidiary, GeneDx, LLC, which is focused on exome and genome tests that translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It operates through GeneDx segment, which primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. Exome sequencing test options include XomeDx, XomeDx Plus, and XomeDxXpress. GeneDx genome sequencing evaluates the protein-coding and non-coding regions of an individual’s nuclear genome. GeneDx genome sequencing test options include GenomeSeqDx and GenomeXpress. It offers a menu of targeted variant testing options to meet the needs of families and healthcare providers. Its subsidiary, Fabric Genomics, Inc., specializes in artificial intelligence-powered genomic interpretation.
Información de la empresa
Símbolo de cotizaciónWGS
Nombre de la empresaGeneDx Holdings Corp
Fecha de salida a bolsaSep 04, 2020
Fundada en2020
Director ejecutivoMs. Katherine A. Stueland
Número de empleados1000
Tipo de seguridadOrdinary Share
Fin del año fiscalSep 04
Dirección333 Ludlow Street
CiudadSTAMFORD
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal06902
Teléfono18887291206
Sitio Webhttps://sema4.com/
Símbolo de cotizaciónWGS
Fecha de salida a bolsaSep 04, 2020
Fundada en2020
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
223.99K
+6.12%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
33.16K
+63.87%
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
20.13K
+179.38%
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
9.13K
+121.71%
Dr. Bryan Dechairo
Dr. Bryan Dechairo
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Katherine A. Stueland
Ms. Katherine A. Stueland
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Jason Michael Ryan, CPA
Mr. Jason Michael Ryan, CPA
Chairman of the Board
Chairman of the Board
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--
Mr. Richard C. (Rick) Pfenniger, Jr.
Mr. Richard C. (Rick) Pfenniger, Jr.
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
223.99K
+6.12%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
33.16K
+63.87%
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
20.13K
+179.38%
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
9.13K
+121.71%
Dr. Bryan Dechairo
Dr. Bryan Dechairo
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Katherine A. Stueland
Ms. Katherine A. Stueland
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de abr
Divisa: USDActualizado: dom., 6 de abr
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Patients with third party insurance
234.70M
76.84%
Institutional customers
65.11M
21.32%
Other
3.29M
1.08%
Self pay patients
2.34M
0.77%
Sin datos
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Patients with third party insurance
234.70M
76.84%
Institutional customers
65.11M
21.32%
Other
3.29M
1.08%
Self pay patients
2.34M
0.77%
Estadísticas de accionistas
Actualizado: sáb., 17 de may
Actualizado: sáb., 17 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Casdin Capital, LLC
12.36%
Corvex Management LP
10.19%
Fidelity Management & Research Company LLC
9.29%
Icahn School of Medicine at Mount Sinai
4.81%
OPKO Health Inc
4.80%
Other
58.54%
Accionistas
Accionistas
Proporción
Casdin Capital, LLC
12.36%
Corvex Management LP
10.19%
Fidelity Management & Research Company LLC
9.29%
Icahn School of Medicine at Mount Sinai
4.81%
OPKO Health Inc
4.80%
Other
58.54%
Tipos de accionistas
Accionistas
Proporción
Hedge Fund
34.94%
Investment Advisor/Hedge Fund
30.52%
Investment Advisor
30.22%
Corporation
10.79%
Research Firm
5.64%
Individual Investor
1.54%
Pension Fund
1.15%
Bank and Trust
0.39%
Sovereign Wealth Fund
0.29%
Participación institucional
Actualizado: mar., 4 de mar
Actualizado: mar., 4 de mar
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q1
362
28.77M
101.81%
-353.08K
2024Q4
341
29.17M
104.22%
+1.72M
2024Q3
289
26.18M
97.50%
+377.48K
2024Q2
262
24.98M
95.33%
+588.25K
2024Q1
260
22.13M
86.19%
+1.41M
2023Q4
271
20.57M
80.67%
-567.28K
2023Q3
283
21.68M
85.29%
-751.02K
2023Q2
291
21.85M
86.03%
-864.88K
2023Q1
296
21.58M
684.27%
+3.47M
2022Q4
305
9.98M
86.27%
+851.42K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Casdin Capital, LLC
3.51M
12.5%
--
--
Dec 31, 2024
Corvex Management LP
2.47M
8.81%
--
--
Dec 31, 2024
Fidelity Management & Research Company LLC
402.39K
1.43%
+348.57K
+647.59%
Dec 31, 2024
Icahn School of Medicine at Mount Sinai
1.37M
4.89%
-1.35M
-49.50%
Feb 21, 2025
OPKO Health Inc
1.37M
4.88%
-800.83K
-36.88%
Nov 20, 2024
Summit Partners Public Asset Management, LLC
1.43M
5.08%
+671.40K
+88.86%
Feb 05, 2025
William Blair Investment Management, LLC
670.00K
2.39%
+508.67K
+315.31%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
1.08M
3.85%
+90.95K
+9.20%
Dec 31, 2024
Goldman Sachs & Company, Inc.
1.06M
3.79%
+34.15K
+3.32%
Dec 31, 2024
The Vanguard Group, Inc.
1.00M
3.58%
+156.77K
+18.51%
Dec 31, 2024
Ver más
ETFs relacionados
Actualizado: vie., 6 de jun
Actualizado: vie., 6 de jun
Nombre
Proporción
Global X Genomics & Biotechnology ETF
2.15%
Simplify Health Care ETF
2.12%
SPDR S&P Health Care Services ETF
1.55%
Harbor Health Care ETF
1.41%
Hypatia Women CEO ETF
0.54%
First Trust Small Cap Growth AlphaDEX Fund
0.53%
Franklin Genomic Advancements ETF
0.38%
First Trust Active Factor Small Cap ETF
0.34%
iShares U.S. Healthcare Providers ETF
0.26%
First Trust Small Cap Core Alphadex Fund
0.26%
Ver más
Global X Genomics & Biotechnology ETF
Proporción2.15%
Simplify Health Care ETF
Proporción2.12%
SPDR S&P Health Care Services ETF
Proporción1.55%
Harbor Health Care ETF
Proporción1.41%
Hypatia Women CEO ETF
Proporción0.54%
First Trust Small Cap Growth AlphaDEX Fund
Proporción0.53%
Franklin Genomic Advancements ETF
Proporción0.38%
First Trust Active Factor Small Cap ETF
Proporción0.34%
iShares U.S. Healthcare Providers ETF
Proporción0.26%
First Trust Small Cap Core Alphadex Fund
Proporción0.26%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Apr 28, 2023
Merger
33<1
Apr 28, 2023
Merger
33<1
Apr 28, 2023
Merger
33<1
Apr 28, 2023
Merger
33<1
Fecha
Tipo
Relación
Apr 28, 2023
Merger
33<1
Apr 28, 2023
Merger
33<1
Apr 28, 2023
Merger
33<1
Apr 28, 2023
Merger
33<1
